drugset / Trial / NCT04459585
A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants
NaSequentialOpen-labelTreatment
Summary
The purpose of this study is to investigate the one-way drug-drug interaction potential of quizartinib on dabigatran etexilate in healthy adult participants.
Timeline
- Start
- 2020-08-28
- Primary completion
- 2020-10-20
- Completion
- 2020-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 150 mg | Oral |
| Subject | Quizartinib | Small molecule | 60 mg | Oral |
Indications
No indication recorded.